Clinical trial

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

NCT00662545

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE4

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2013-05-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Hepatitis Bunresolved

Interventions

Entecavir with continued standard of care antiretroviral therapyDRUG

continued standard of care with tenofovir in addition to emtricitabine or lamivudineDRUG

Sponsors & collaborators

University of California, San Franciscolead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00662545 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.